Drop by our booth #517 at the PDA Week 2025 / PDA Annual Meeting in Palm Springs, California, April 6 – 11, 2025. The event will be held at the Palm Springs Convention Centre.
The conference focuses on a wide spectrum of topics like Management of Outsourced Operations, Quality and Compliance Management, Innovations in cGMP Facility Design and Digitization, The Multiverse of Manufacturing Challenges, AI/ML in Pharmaceutical Quality: Advancements and Challenges, Data Governance, Management, Integrity, and Digitalization, Microbiology/Environmental Monitoring, a visit to Dendreon’s* innovative science and cellular therapy manufacturing facility, the largest plasma fractionation site in Takeda, The Los Angeles manufacturing facility visit, best practices and strategies for navigating ATMP regulatory submission etc.
The PDA Annual Meeting highlights include:
- Lightning presentations
- Guided poster tours
- Roundtable discussions
- Dynamic and current industry topics which allow you gain strategic approaches and practical solutions to help you overcome the difficult challenges in your industry and advance in your professional development.
- Chance to meet with globally reputed industry expertise.
Two of our colleagues from Regulatory Compliance Associates (RCA) will be involved in activities during the show.
Susan Schniepp, Co-Chair on the PDA Board of Directors and Distinguished Fellow at RCA, will be helping moderate a few of the presentations during the event and will also be involved in panel discussions.
Arie Anahory, Global Head of Operations at RCA, will be co-leading and working alongside the PDA in the Drug Compounding Interest Group. The group intends to bring together industry leaders involved in pharmaceutical compounding operating under Sections 503A and 503B of the FD&C Act. The group will focus on fostering collaboration and dialogue surrounding discussions on emerging regulations, best practices, and navigating the landscape of compliance. Learn more.
You can find full details about PDA Week 2025 here.
